BioCryst Pharmaceuticals
BCRX
#4738
Rank
S$2.16 B
Marketcap
$10.46
Share price
-4.52%
Change (1 day)
49.42%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of September 2024 : S$1.08 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is S$1.08 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$1.08 B9.64%
2022-12-31S$0.99 B23.94%
2021-12-31S$0.80 B116.9%
2020-12-31S$0.36 B223.99%
2019-12-31S$0.11 B35.13%
2018-12-31S$84.45 M15.4%
2017-12-31S$73.19 M-5.87%
2016-12-31S$77.75 M82.14%
2015-12-31S$42.68 M7.69%
2014-12-31S$39.64 M4.29%
2013-12-31S$38 M3.6%
2012-12-31S$36.68 M-5.57%
2011-12-31S$38.85 M
2000-12-31S$0.01 M
1997-12-31S$0.16 M-59.84%
1996-12-31S$0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$0.99 B-8.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.87 B 72.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.31 B-71.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$31.24 B 2,785.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.13 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.76 B 2,556.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.15 B 6.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.23 M-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA